Limerston-backed Arch Sciences acquires Apex Scientific
Limerston Capital Partners portfolio company Arch Sciences has acquired Apex Scientific, a provider of laboratory services.
The firm provided fresh capital to support the acquisition, drawn from its debut fund, which closed on €223.5m in August 2017.
Formerly called Crawford Scientific, Limerston acquired the company in October 2017 from Maven Capital Partners. The sale generated a 4.7x return for the vendor after a three-year holding period, equivalent to an IRR of 70%.
This is part of Arch's international expansion plan, and its first step into the EU market. Apex's management team will stay on with the company.
Company
Apex Scientific provides chromatography, sample preparation, liquid handling and related services in Ireland. It is based in Maynooth and was founded in 2007.
People
Limerston Capital Partners - Martim Avillez; Joao Rosa (founding partners).
Apex Scientific – Andy Pepper (CEO).
Advisers
Acquirer – Grant Thornton (corporate finance); Pinsent Masons (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









